Assessing the impact of buprenorphine for opioid use disorder on infectious disease management.
- DOI
- 10.1016/j.josat.2026.210010
- Published
- 2026 Oct
- Container
- Journal of substance use and addiction treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.josat.2026.210010,
title = {Assessing the impact of buprenorphine for opioid use disorder on infectious disease management.},
author = {Lo J and Thanataveerat A and Manfredo A and Falk J and Zeng N and Wall S and Ryan T and Pratt W and El-Dalati S and Gaiazov S},
year = {2026},
journal = {Journal of substance use and addiction treatment},
doi = {10.1016/j.josat.2026.210010},
url = {https://doi.org/10.1016/j.josat.2026.210010}
}RIS
TY - JOUR TI - Assessing the impact of buprenorphine for opioid use disorder on infectious disease management. AU - Lo J AU - Thanataveerat A AU - Manfredo A AU - Falk J AU - Zeng N AU - Wall S AU - Ryan T AU - Pratt W AU - El-Dalati S AU - Gaiazov S PY - 2026 JO - Journal of substance use and addiction treatment DO - 10.1016/j.josat.2026.210010 UR - https://doi.org/10.1016/j.josat.2026.210010 ER -
APA
J, L., A, T., A, M., J, F., N, Z., S, W., T, R., W, P., S, E., & S, G. (2026). Assessing the impact of buprenorphine for opioid use disorder on infectious disease management.. Journal of substance use and addiction treatment. https://doi.org/10.1016/j.josat.2026.210010
Source records
- pubmed · retrieved 2026-09-25T07:28:24.425Z